Developing an ars moriendi nova in the face of the COVID-19 pandemic – a prospective mixed-methods survey

Organizational Data

DRKS-ID:
DRKS00023789
Recruitment Status:
Recruiting complete, study continuing
Date of registration in DRKS:
2020-12-18
Last update in DRKS:
2021-06-24
Registration type:
Prospective

Acronym/abbreviation of the study

ArsMoriendi-COVID

URL of the study

No Entry

Brief summary in lay language

Since the Spanish Flu in 1918, there has been no other virus disease in the past century with such high an impact on all societies around the globe as SARS-CoV-2. This is particularly true for Freiburg and its surrounding region since it was severely hit by the first wave and is still reporting high numbers of infections during the second wave of the Coronavirus pandemic in Germany. Globally, the scientific focus is on researching ways to treat the disease and on developing effective vaccinations. Those directly affected by the pandemic, specifically those working within the health care system and directly caring for COVID-19 patients need to cope with a multitude of practical and psychological challenges. Our aim is to describe attitudes and reactions of people during the Coronavirus pandemic. We would like to focus on stressful experiences during the pandemic, coping with stress and well-being and ask about meaning-making and posttraumatic growth in the context of the pandemic. Religious attitudes, faith and spirituality as possible resources that help coping will be explored. Design: This is a cross-sectional mixed-methods study using an online survey of students and staff member of both Freiburg university and Freiburg university hospital, and qualitative interviews via telephone to elicit more in-depth answers about the topics of coping during the Coronavirus crisis.

Brief summary in scientific language

Background: Since the Spanish Flu in 1918, there has been no other virus disease in the past century with such high an impact on all societies around the globe as SARS-CoV-2. Research to date focuses on the medical treatment of this infectious disease next to the short-term psychological impact on health care professionals and the general public. In this study, we propose to determine the holistic bio-psych-social-spiritual impact of the Coronavirus pandemic in a region in Germany characterised by high COVID-19 incidence. We propose to study how the pandemic may lead the individual to a different way of reflecting on uncertainty and mortality when witnessing infections of family members and friends or when being confronted with the fear of experiencing a severe infection themselves. The confrontation with vulnerability, finitude and mortality as part of the uncertainty and contingencies in life is a challenge and opportunity during the pandemic to develop, re-learn and practise a new ars moriendi. Aim: The aim of this project is to systematically develop, renew and empirically establish approaches to an ars moriendi nova in the face of the worldwide COVID-19 pandemic. The project focuses on bio-psycho- social-spiritual, philosophical, theological, and medical aspects of experiences, living with and coping with the pandemic. Our main objectives are: 1) To describe and establish changes in attitudes, behaviours and worldview/self-image; 2) To describe the specific psycho-social-spiritual impact of COVID-19 by exploring coping mechanisms, social and spiritual aspects; 3) To describe respondent’s quality of life, life satisfaction, and their degree of distress in response to trauma; 4) To measure and explore their death awareness and death-related cognitions; 5) To determine moderators (demographic, cultural and lifestyle factors) and mediators; 6) To integrate the quantitative and qualitative findings of the ars moriendi nova into a framework. Design: This is a prospective, mixed-methods cross-sectional study using a standardised online survey and qualitative, semi-structured interviews with staff members and students of both Freiburg University and Freiburg University Hospital. A quota sample of both scientific and non-scientific personnel and students as well as a purposive sample for interviews will be drawn. The online survey uses the following questionnaires: sociodemographic details and infection status (own infection or infection of family members/friends), health behaviour and spiritual/religious behaviour, negative consequences and stress due to the Coronavirus pandemic (Büssing et al., 2020a); Brief Multidimensional Life Satisfaction Scale BLMSS-10; Gratitude/Awe Questionnaire (Büssing, Rechia & Baumann, 2018), WHO-5 Wellbeing Index, Perceived Changes Questionnaire (Büssing et al., 2020b), Death Reflection Scale (Yuan et al., 2019). Topics of the online survey will be explored in-depth in the qualitative telephone interviews. Quantitative data will be analysed with multiple regression models and a multiple mediation model for modelling determinants and mediating factors for the outcome death reflection. The qualitative analysis will use interpretative-phenomenological methodology, combined with elements of Grounded theory and framework analysis. Quantitative and qualitative findings will be integrated into an ars moriendi nova model. Conclusion: This foundational framework can help vulnerable groups to make sense of their experiences during the pandemic. It can serve as a foundation for developing guidance, interventions, and resources to help people cope with the impact of the pandemic, particularly those at the frontline like health care workers.

Health condition or problem studied

ICD10:
U07.1 - COVID-19, virus identified
Free text:
Any medical conditions that may exist
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Observational study - Students and staff members of Freiburg University and Freiburg University Hospital complete a cross-sectional online survey and qualitative telephone interviews about their experiences and change in attitudes during the Coronavirus pandemic.

Endpoints

Primary outcome:
Changes in attitudes, behaviours and well-being, dealing with one’s own mortality during and through the Coronavirus pandemic (measured via validated, self-report questionnaires)
Secondary outcome:
Self-reported experiences, attitudes and changes in these, reflection of one’s own mortality and dealing with one’s own finiteness during the Coronavirus pandemic (measured via semi-structured qualitative telephone interviews)

Study Design

Purpose:
Other
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study continuing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • University medical center Freiburg im Breisgau
  • Other Albert-Ludwigs-Universität Freiburg Freiburg im Breisgau

Recruitment period and number of participants

Planned study start date:
2021-02-01
Actual study start date:
2021-03-01
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
850
Final Sample Size:
2085

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Staff members of two institutions with main work contract and including all status groups (scientific and non-scientific staff members, health care professionals involved in patient care at the university hospital), students of Freiburg University

Exclusion Criteria

Staff members and students not directly affiliated with Freiburg University or Freiburg University Hospital.

Addresses

Primary Sponsor

Address:
Universitätsklinikum Freiburg
Hugstetter Strasse 49
79095 Freiburg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uniklinik-freiburg.de
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Klinik für Palliativmedizin, Universitätsklinikum Freiburg
Prof. Dr. Gerhild Becker
Robert-Koch-Str. 3
79106 Freiburg
Germany
Telephone:
+49 761 270 95417
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/palliativmedizin.html

Contact for Public Queries

Address:
Klinik für Palliativmedizin, Universitätsklinikum Freiburg
Dr. Christina Ramsenthaler
Robert-Koch-Str. 3
79106 Freiburg
Germany
Telephone:
+49 761 270 94230
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/palliativmedizin.html

Principal Investigator

Address:
Klinik für Palliativmedizin, Universitätsklinikum Freiburg
Prof. Dr. Gerhild Becker
Robert-Koch-Str. 3
79106 Freiburg
Germany
Telephone:
+49 761 270 95417
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/palliativmedizin.html

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Klinik für Palliativmedizin, Universitätsklinikum Freiburg
Robert-Koch-Str. 3
79106 Freiburg
Germany
Telephone:
+49 761 270 95417
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/palliativmedizin.html

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
Engelberger Str. 21
79106 Freiburg
Germany
Telephone:
+49-761-27072600
Fax:
+49-761-27072630
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2020-10-06
Ethics committee number:
20-1160
Vote of the Ethics Committee:
Approved
Date of the vote:
2020-11-05

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
Yes
IPD Sharing Plan:
Individual participant quantitative data underlying the results can be shared after de-identification and in the format of a correlation matrix to individuals whose proposed use of the data has been approved by an independent review committee identified for this purpose. Researchers wishing to work with the data need to contact Prof. Dr. Gerhild Becker gerhild.becker@uniklink-freiburg.de with a research proposal and analysis plan for data usage. Proposals for individual participant meta-analysis may be submitted up to 36 months following article publication. Data from the qualitative interviews are not available for data sharing.

Study protocol and other study documents

Study protocols:
Prüfprotokoll Studie
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry